文献速递哮喘呼吸危重症与机械通气

无创通气在重症哮喘急性发作患者中的应用

Noninvasive Ventilation Use in Critically Ill Patients with Acute Asthma Exacerbations.
PubMed 文献 · Am J Respir Crit Care Med · 2020-01-01

该回顾性队列研究利用美国682家医院2010-2017年数据,纳入53,654例因哮喘急性发作入住ICU的患者,评估无创通气与后续有创机械通气及院内死亡的关系。结果显示无创通气使用与较低的有创通气几率(OR 0.36)和院内死亡率(OR 0.48)相关,但合并肺炎和严重脓毒症者需谨慎使用。

要点

  • 哮喘急性发作入住ICU患者中,无创通气使用与较低的有创通气和院内死亡风险相关。
  • 接受无创通气者中22.3%后续需要有创通气,其中4.5%死亡。
  • 合并肺炎或严重脓毒症时,无创通气应谨慎使用。

核心结论

  • 哮喘急性发作期间使用无创通气与改善的结局相关,但合并急性共病时应谨慎使用。

研究设计与样本

  • 回顾性队列研究,使用美国682家医院2010-2017年行政数据,纳入53,654例因哮喘急性发作入住ICU的患者。

主要发现

  • 13,540例(25.2%;95%CI 24.9-25.6%)接受无创通气,14,498例(27.0%;95%CI 26.7-27.4%)接受有创机械通气,1,291例(2.4%;95%CI 2.3-2.5%)死亡。
  • 接受无创通气者中3,013例(22.3%;95%CI 21.6-23.0%)后续需要有创机械通气,其中136例(4.5%;95%CI 3.8-5.3%)死亡。
  • 在所有模型中,无创通气与较低的有创机械通气几率相关(调整GEE OR 0.36;95%CI 0.32-0.40)和较低的院内死亡几率相关(OR 0.48;95%CI 0.40-0.58)。
  • 接受无创通气后需要有创通气的患者更可能合并肺炎和严重脓毒症。

临床怎么用

  • 对哮喘急性发作入住ICU的患者,可考虑使用无创通气以降低有创通气和死亡风险。
  • 合并肺炎或严重脓毒症时,应谨慎评估无创通气的使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Noninvasive ventilation decreases the need for invasive mechanical ventilation and mortality among patients with chronic obstructive pulmonary disease but has not been well studied in asthma.Objectives: To assess the association between noninvasive ventilation and subsequent need for invasive mechanical ventilation and in-hospital mortality among patients admitted with asthma exacerbation to the ICU.Methods: We performed a retrospective cohort study using administrative data collected during 2010-2017 from 682 hospitals in the United States. Outcomes included receipt of invasive mechanical ventilation and in-hospital mortality. Generalized estimating equations, propensity-matched models, and marginal structural models were used to assess the association between noninvasive ventilation and outcomes.Measurements and Main Results: The study population included 53,654 participants with asthma exacerbation. During the study period, 13,540 patients received noninvasive ventilation (25.2%; 95% confidence interval [CI], 24.9-25.6%), 14,498 underwent invasive mechanical ventilation (27.0%; 95% CI, 26.7-27.4%), and 1,291 died (2.4%; 95% CI, 2.3-2.5%). Among those receiving noninvasive ventilation, 3,013 patients (22.3%; 95% CI, 21.6-23.0%) required invasive mechanical ventilation after first receiving noninvasive ventilation, 136 of whom died (4.5%; 95% CI, 3.8-5.3%). Across all models, the use of noninvasive ventilation was associated with a lower odds of receiving invasive mechanical ventilation (adjusted generalized estimating equation odds ratio, 0.36; 95% CI, 0.32-0.40) and in-hospital mortality (odds ratio, 0.48; 95% CI 0.40-0.58). Those who received noninvasive ventilation before invasive mechanical ventilation were more likely to have comorbid pneumonia and severe sepsis.Conclusions: Noninvasive ventilation use during asthma exacerbation was associated with improved outcomes but should be used cautiously with acute comorbid conditions.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Althoff MD, Holguin F, Yang F, et al. Noninvasive Ventilation Use in Critically Ill Patients with Acute Asthma Exacerbations. Am J Respir Crit Care Med. 2020. PMID: 32663410. doi:10.1164/rccm.201910-2021OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。